April 25, 2018 / 9:58 PM / 3 months ago

BRIEF-Biomarin Pharmaceutical Q1 GAAP Loss Per Share $0.26

April 25 (Reuters) - Biomarin Pharmaceutical Inc:

* BIOMARIN ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

* Q1 REVENUE $373.4 MILLION VERSUS I/B/E/S VIEW $348.7 MILLION

* Q1 GAAP LOSS PER SHARE $0.26

* Q1 EARNINGS PER SHARE VIEW $-0.17 — THOMSON REUTERS I/B/E/S

* SEES FY 2018 REVENUE ABOUT $1.5 BILLION

* AS OF MARCH 31, 2018, BIOMARIN HAD CASH, CASH EQUIVALENTS AND INVESTMENTS TOTALING ABOUT $1.7 BILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below